Global Health Institute, Department of Epidemiology and Social Medicine, Faculty of Medicine and Health Sciences, University of Antwerp, Gouverneur Kinsbergencentrum, Doornstraat 331, Wilrijk, 2610, Antwerp, Belgium.
Département des Sciences de la Santé Publique, Direction de la Formation, Institut National de Santé Publique, B.P, 6807, Bujumbura, Burundi.
Infect Dis Poverty. 2018 Jul 4;7(1):66. doi: 10.1186/s40249-018-0447-y.
Schistosomiasis and soil-transmitted helminthiasis (STH) are endemic diseases in Burundi. STH control is integrated into health facilities (HF) across the country, but schistosomiasis control is not. The present study aimed to assess the capacity of HF for integrating intestinal schistosomiasis case management into their routine activities. In addition, the current capacity for HF-based STH case management was evaluated.
A random cluster survey was carried out in July 2014, in 65 HF located in Schistosoma mansoni and STH endemic areas. Data were collected by semi-quantitative questionnaires. Staff with different functions at the HF were interviewed (managers, care providers, heads of laboratory and pharmacy and data clerks). Data pertaining to knowledge of intestinal schistosomiasis and STH symptoms, human and material resources and availability and costs of diagnostic tests and treatment were collected.
Less than half of the 65 care providers mentioned one or more major symptoms of intestinal schistosomiasis (abdominal pain 43.1%, bloody diarrhoea 13.9% and bloody stool 7.7%). Few staff members (15.7%) received higher education, and less than 10% were trained in-job on intestinal schistosomiasis case management. Clinical guidelines and laboratory protocols for intestinal schistosomiasis diagnosis and treatment were available in one third of the HF. Diagnosis was performed by direct smear only. Praziquantel was not available in any of the HF. The results for STH were similar, except that major symptoms were more known and cited (abdominal pain 69.2% and diarrhoea 60%). Clinical guidelines were available in 61.5% of HF, and albendazole or mebendazole was available in all HF.
The current capacity of HF for intestinal schistosomiasis and STH detection and management is inadequate. Treatment was not available for schistosomiasis. These issues need to be addressed to create an enabling environment for successful integration of intestinal schistosomiasis and STH case management into HF routine activities in Burundi for better control of these diseases.
血吸虫病和土壤传播性蠕虫病(STH)在布隆迪流行。该国的卫生机构(HF)整合了 STH 控制,但血吸虫病控制并未整合。本研究旨在评估 HF 将肠道血吸虫病病例管理纳入其常规活动的能力。此外,还评估了 HF 基于 STH 病例管理的现有能力。
2014 年 7 月,在曼氏血吸虫和 STH 流行地区的 65 个 HF 中进行了随机聚类调查。数据通过半定量问卷收集。采访了 HF 中具有不同职能的人员(管理人员、医护人员、实验室和药房负责人以及数据录入员)。收集了有关肠道血吸虫病和 STH 症状、人力和物力资源以及诊断测试和治疗的可用性和成本的知识。
不到一半的 65 名医护人员提到了一种或多种肠道血吸虫病的主要症状(腹痛 43.1%,血便 13.9%,血便 7.7%)。很少有工作人员(15.7%)接受过高等教育,不到 10%的人接受过肠道血吸虫病病例管理方面的在职培训。三分之一的 HF 拥有肠道血吸虫病诊断和治疗的临床指南和实验室方案。诊断仅通过直接涂片进行。所有 HF 均无吡喹酮。STH 的结果相似,只是主要症状更被了解和引用(腹痛 69.2%,腹泻 60%)。61.5%的 HF 拥有临床指南,所有 HF 都提供阿苯达唑或甲苯咪唑。
HF 检测和管理肠道血吸虫病和 STH 的现有能力不足。没有针对血吸虫病的治疗方法。需要解决这些问题,为成功将肠道血吸虫病和 STH 病例管理纳入布隆迪 HF 的常规活动创造有利环境,以更好地控制这些疾病。